Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: Safety and feasibility

Heart Rhythm

Volumn 7, Issue 8, 2010, Pages 1036-1042

  Santangeli, Pasquale ^a,e,f   Di Biase, Luigi ^a,b,c   Lakkireddy, Dhanunjay ^d   Burkhardt, J David ^a   Pillarisetti, Jayasree ^d   Michowitz, Yoav ^f   Sanchez, Javier E ^a   Horton, Rodney ^a,b   Mohanty, Prasant ^a   Gallinghouse, G Joseph ^a   Dello Russo, Antonio ^e   Casella, Michela ^e   Pelargonio, Gemma ^e   Santarelli, Pietro ^e   Verma, Atul ^g   Narasimhan, Calambur ^h   Shivkumar, Kalyanam ^f   Natale, Andrea ^a,b,i  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b The University of Texas at Austin   (United States)

^c UNIVERSITY OF FOGGIA   (Italy)

^d UNIVERSITY OF KANSAS   (United States)

^e CATHOLIC UNIVERSITY   (Italy)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^h CARE Hospital   (India)

ⁱ STANFORD UNIVERSITY   (United States)

Author keywords

Catheter ablation; Hypertrophic cardiomyopathy; Outcomes; Ventricular tachycardia

Indexed keywords

ADULT; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; ELECTROPHYSIOLOGY; ENDOCARDIUM; EPICARDIUM; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SAFETY; TREATMENT OUTCOME;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 77956855865     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2010.05.022     Document Type: Article

References (33)

1. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320
2. P. Spirito, C. Rapezzi, C. Autore, et al. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia Circulation 90 1994 2743 2747
3. B.J. Maron, W.K. Shen, M.S. Link, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy N Engl J Med 342 2000 365 373
4. B.J. Maron, N. Sato, W.C. Roberts, J.E. Edwards, and R.S. Chandra Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum Comparison of fetuses and infants with and without congenital heart disease and patients with hypertrophic cardiomyopathy Circulation 60 1979 685 696
5. B.J. Maron, T.J. Anan, and W.C. Roberts Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy Circulation 63 1981 882 894
6. W.J. McKenna, C.M. Oakley, D.M. Krikler, and J.F. Goodwin Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia Br Heart J 53 1985 412 416
7. F. Cecchi, I. Olivotto, A. Montereggi, et al. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population Heart 79 1998 331 336
8. B.J. Maron, P. Spirito, and W.K. Shen Implantable cardioverter- defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy JAMA 298 2007 405 412 (Pubitemid 47124061)
9. Y. Okumura, I. Watanabe, K. Ohkubo, and S. Saito Successful catheter ablation for incessant ventricular tachycardia in a patient with hypertrophic cardiomyopathy Circ J 71 2007 1164 1168
10. M. Casella, A. Dello Russo, G. Pelargonio, and C. Tondo Sustained right ventricular tachycardia originating close to defibrillator lead tip in hypertrophic cardiomyopathy J Cardiovasc Electrophysiol 18 2007 994 997
11. M. Mantica, P. Della Bella, and V. Arena Hypertrophic cardiomyopathy with apical aneurysm: a case of catheter and surgical therapy of sustained monomorphic ventricular tachycardia Heart 77 1997 481 483
12. K.K. Lim, B.J. Maron, and B.P. Knight Successful catheter ablation of hemodynamically unstable monomorphic ventricular tachycardia in a patient with hypertrophic cardiomyopathy and apical aneurysm J Cardiovasc Electrophysiol 20 2009 445 447
13. L.M. Rodriguez, J.L. Smeets, C. Timmermans, et al. Radiofrequency catheter ablation of sustained monomorphic ventricular tachycardia in hypertrophic cardiomyopathy J Cardiovasc Electrophysiol 8 1997 803 806
14. B.J. Maron, W.J. McKenna, G.K. Danielson, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713
15. E. Sosa, M. Scanavacca, A. d'Avila, and F. Pilleggi A new technique to perform epicardial mapping in the electrophysiology laboratory J Cardiovasc Electrophysiol 7 1996 531 536 (Pubitemid 126426338)
16. B.J. Maron, W.C. Roberts, and S.E. Epstein Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients Circulation 65 1982 1388 1394
17. P. Nicod, R. Polikar, and K.L. Peterson Hypertrophic cardiomyopathy and sudden death N Engl J Med 318 1988 1255 1257
18. G.F. Tomaselli, and E. Marban Electrophysiological remodeling in hypertrophy and heart failure Cardiovasc Res 42 1999 270 283
19. C.M. Wolf, I.P. Moskowitz, S. Arno, et al. Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia Proc Natl Acad Sci U S A 102 2005 18123 18128
20. C. Basso, G. Thiene, D. Corrado, et al. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia Hum Pathol 31 2000 988 998
21. A.M. Varnava, P.M. Elliott, C. Baboonian, et al. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease Circulation 104 2001 1380 1384
22. A.S. Adabag, B.J. Maron, E. Appelbaum, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance J Am Coll Cardiol 51 2008 1369 1374
23. D.H. Kwon, N.G. Smedira, E.R. Rodriguez, et al. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia J Am Coll Cardiol 54 2009 242 249
24. A. Rudolph, H. Abdel-Aty, S. Bohl, et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling J Am Coll Cardiol 53 2009 284 291
25. H. Satoh, F. Matoh, K. Shiraki, et al. Delayed enhancement on cardiac magnetic resonance and clinical, morphological, and electrocardiographical features in hypertrophic cardiomyopathy J Card Fail 15 2009 419 427
26. H. Calkins, A. Epstein, D. Packer, et al. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study Cooled RF Multi Center Investigators Group J Am Coll Cardiol 35 2000 1905 1914
27. K. Yokoyama, H. Nakagawa, F.H. Wittkampf, et al. Comparison of electrode cooling between internal and open irrigation in radiofrequency ablation lesion depth and incidence of thrombus and steam pop Circulation 113 2006 11 19
28. M.S. Maron, J.J. Finley, J.M. Bos, et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy Circulation 118 2008 1541 1549
29. T.N. James, and T.K. Marshall De subitaneis mortibus XII. Asymmetrical hypertrophy of the heart Circulation 51 1975 1149 1166
30. L. Fananapazir, and S.E. Epstein Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone Am J Cardiol 67 1991 175 182
31. L. Fananapazir, C.M. Tracy, M.B. Leon, et al. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy A consecutive analysis in 155 patients Circulation 80 1989 1259 1268
32. B.J. Maron, R.O. Bonow, R.O. Cannon 3rd, M.B. Leon, and S.E. Epstein Hypertrophic cardiomyopathy Interrelations of clinical manifestations, pathophysiology, and therapy (2) N Engl J Med 316 1987 844 852
33. B.J. Maron, R.O. Bonow, R.O. Cannon 3rd, M.B. Leon, and S.E. Epstein Hypertrophic cardiomyopathy Interrelations of clinical manifestations, pathophysiology, and therapy (1) N Engl J Med 316 1987 780 789